TMCnet

FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.

Following eyonis® LCS' FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...
The Fast Mode

Samsung Advances AI-RAN Commercialization with Virtualized RAN & NVIDIA AI Infrastructure

Samsung Electronics announced the successful completion of a multi-cell test at its R&D center, combining Samsung’s virtualized RAN (vRAN) software with NVIDIA’s accelerated computing platform. The ...
MedTech Intelligence

Decision Criteria for Technology Commercialization of Medical Devices in 2026

Commercialization strategy in 2026 and beyond is more than a checklist. It requires a new mindset where cybersecurity is seen as a patient safety imperative, data is treated as a critical strategic ...
HUB

JHTV Open House: Software-related commercialization

You are invited to JHTV's Open House focused on software commercialization at JHU, Thursday, Feb. 29. This event will be held at the Homewood campus in the Malone Building, room G33/G35, where we will ...